Find the Perfect Plan for Your Investment Journey
Last Price
52 Week Range
$160.19 - $289.46
Next Earnings Date
May 08 2025
Next Earnings Date
May 08 2025
Last Price
Market Cap | $17.65B |
EV | $18.13B |
Shares Outstanding | 70.72M |
Beta | 1.30 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | $312.14 |
P/E 2025E | 60.24x |
P/Revenue 2025E | 7.21x |
Revenue | 23.50% |
EPS | 62.90% |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | 17.00% |
EPS | 24.40% |
Operating Cash Flow | 17.00% |
Free Cash Flow | 17.80% |
Gross Margin 2025E | 70.45% |
Net Profit Margin 2025E | 12.82% |
ROE 2025E | 20.93% |
ROCE 2024 | 43.03% |
DPS 2025E | $0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Insulet Corporation
PODD
Sector
Healthcare
Industry
Medical - Devices
CEO
Hollingshead, James
Employees
3,900
Website
www.insulet.comIPO Date
2007-05-15
Headquarters
100 Nagog Park, Acton, Massachusetts, 01720, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved